An oral BRAF inhibitor for the treatment of late-stage metastatic melanoma with the gene mutation BRAF V600E.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An oral BRAF inhibitor for the treatment of late-stage metastatic melanoma with the gene mutation BRAF V600E.
If you have a Hayes login, click here to view the full report on the Knowledge Center.